Aims Exenatide, a glucagon-like-peptide-1 analogue, increases myocardial salvage in
experimental settings with coronary occlusion and subsequent reperfusion. We evaluated …

Background—Distal embolization during primary percutaneous coronary intervention (PCI)
for ST-elevation myocardial infarction may result in reduced myocardial perfusion, infarct …

Background—Quantitative flow ratio (QFR) is a novel diagnostic modality for functional
testing of coronary artery stenosis without the use of pressure wires and induction of …

Background In low-risk patients, the zotarolimus-eluting stent has been shown to reduce
rates of restenosis without increasing the risk of stent thrombosis. We compared the efficacy …

Background Third-generation biodegradable polymer drug-eluting stents might reduce the
risk of stent thrombosis compared with first-generation permanent polymer drug-eluting …

Background—Among drug-eluting stents released to date, the sirolimus-eluting stent has
demonstrated the least amount of late lumen loss, but its efficacy and safety have not been …

Background—Coronary drug-eluting stents with biodegradable polymers have been
designed to improve safety and efficacy. Methods and Results—The Scandinavian …

Background New-generation drug-eluting coronary stents have reduced the risk of coronary
events, especially in patients with complex disease or lesions. To what extent different stent …

Background In head-to-head comparisons of coronary drug-eluting stents, the primary
endpoint is traditionally assessed after 9–12 months. However, the optimum timepoint for …

Aims To assess the use of downstream coronary angiography (ICA) and short-term safety of
frontline coronary CT angiography (CTA) with selective CT-derived fractional flow reserve …